I also am expecting this indication to be a major enterprise value mover. If the results are as strong as you indicate or even moderately better, we might have a halt in the trial and a breakthrough designation given, as there aren't many (if any) good alternatives.
Brilacidin success makes this a 5-10B business. Kevetrin is the moon shot and beyond if it works.
I've added yesterday and today based on the advancement of the trials. I'm happy to pick up more shares at this price point. When I was buying in the $4s, I never thought I'd see the $3s again let alone $2s.
The time to buy is when there is blood in the streets. I think that can be said about CTIX's 50% retrace from the highs and the level of panic by some on the board.